The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Cardiome Pharma Corp crosses above 125-day moving average

Cardiome Pharma Corp closed up sharply Wednesday, rallying $0.37 or 3.25% to $11.75 and crossing above its 125-day moving average. Over the last five days, shares have gained 2.17% and 10.02% year to date. Shares have outperformed the S&P TSX by 68.15% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.48
Updated July 29 3:57 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-67.91%

Although this company's net profit margin is negative, it is above the industry average and implies that Cardiome Pharma Corp is operating more effectively than other companies in the industry.
Company Books

S&P TSX1.59%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue5788
Total other revenue--------
Total revenue5788
Gross profit4355
Total cost of revenue1432
Total operating expense8131112
Selling / general / administrative6989
Research & development0000
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)--000
Other operating expenses, total--------
Operating income-3-6-3-4
Interest income (expense), net non-operating-1-100
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-7-4-4
Income after tax-4-6-4-4
Income tax, total0000
Net income-4-6-4-4
Total adjustments to net income--------
Net income before extra. items-4-6-4-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-6-4-4
Inc. avail. to common incl. extra. items-4-6-4-4
Diluted net income-4-6-4-4
Dilution adjustment--------
Diluted weighted average shares17171717
Diluted EPS excluding extraordinary itemsvalue per share-0.23-0.39-0.26-0.26
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.23-0.39-0.26-0.26